Vericel (VCEL) Earnings Date & Reports

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

VCEL is expected to report earnings to fall 80.75% to -2 cents per share on August 05

Q2'26

Est.

$-0.02

Q1'26

Beat

by $0.03

Q4'25

Beat

by $0.06

Q3'25

Beat

by $0.11

Q2'25

Beat

by $0.02

The last earnings report on May 07 showed earnings per share of -11 cents, beating the estimate of -15 cents. With 167.05K shares outstanding, the current market capitalization sits at 2.07B.

View a ticker or compare two or three

Compare

VCEL

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for VCEL